Therapeutic platforms for protein, RNA, and cell-based therapeutics can facilitate proof-of-concept studies for the development of innovative treatment strategies. The specificity of biotherapeutic platforms makes it popular for the treatment of some diseases refractory to small molecule therapy. We have developed these platforms that include instrumentation and knowledge expertise, aiming to accelerate early research for quick transition to the development of a treatment modality.